Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Gauzy Ltd. due to allegations of violations of federal securities laws, with a deadline for investors to seek lead plaintiff status by February 6, 2026 [1][3]. Summary by Sections Allegations Against Gauzy Ltd. - The complaint alleges that Gauzy Ltd. and its executives made false and misleading statements and failed to disclose critical financial issues regarding three French subsidiaries, which lacked the means to meet their debts [3]. - It is claimed that these subsidiaries were likely to face insolvency proceedings, which could trigger defaults under the company's senior secured debt facilities [3]. Market Reaction - On November 14, 2025, Gauzy Ltd. announced the commencement of French insolvency proceedings against its subsidiaries, leading to a significant drop in share price [4]. - The company's stock fell by $2.00 per share, nearly 50%, closing at $2.02 on November 17, 2025, amid unusually heavy trading volume [5]. Legal Proceedings - The lead plaintiff in the class action will be the investor with the largest financial interest who can adequately represent the class [6]. - Faruqi & Faruqi encourages individuals with information regarding Gauzy's conduct to come forward, including whistleblowers and former employees [7].

Core Viewpoint - Edelson Lechtzin LLP is investigating Ardent Health, Inc. for potential violations of federal securities laws due to allegations of misleading business information provided to investors [1]. Company Overview - Ardent Health, founded in 2001, operates a network of 30 hospitals and over 280 care locations across six states, catering to mid-sized communities with a diverse range of healthcare services [2]. Alleged Wrongdoing - On November 12, 2025, Ardent Health reported third-quarter results that did not meet expectations, primarily due to an increase in insurance claim denials and a $54 million adjustment related to prior claims and litigation in New Mexico involving a former provider [3]. - The company revised its accounting estimates, leading to an earlier recognition of reserves, which resulted in a $43 million reduction in reported revenue for the quarter [3]. - Following this announcement, Ardent Health's stock price dropped by over 33% on November 13, 2025 [4].

NEW YORK, Dec. 18, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Firefly Aerospace Inc. (NASDAQ: FLY). Shareholders who purchased shares of FLY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/firefly-aerospace-inc-loss-submission-form/?id=180688&from=4  CLASS PERIOD: This ...

NEW YORK, Dec. 18, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Primo Brands Corporation / Primo Water Corporation (NYSE: PRMB). Shareholders who purchased shares of PRMB during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: ALLEGATIONS: According to the filed complaint, defendants made false statements and/or conceale ...

Core Viewpoint - Rezolute, Inc. (NASDAQ: RZLT) experienced a significant decline in share price, falling over 85% after the failure of its Phase 3 sunRIZE study in congenital hyperinsulinism, which did not meet its primary or key secondary endpoints. This has raised concerns about potential securities law violations due to misleading statements made by the company regarding earlier data and program outlook [2][4]. Group 1: Company Performance - The share price of Rezolute, Inc. dropped more than 85% on December 11, 2025, following the announcement of the failed clinical trial results [2]. - The Phase 3 sunRIZE study aimed at treating congenital hyperinsulinism did not achieve its primary or key secondary endpoints, leading to investor losses [2]. Group 2: Legal Investigation - Block & Leviton is investigating Rezolute, Inc. for potential securities law violations and may file an action to recover losses for affected investors [4]. - Investors who purchased common stock in Rezolute, Inc. and experienced a decline in share value may be eligible to participate in the investigation, regardless of whether they sold their shares [3]. Group 3: Investor Support - Block & Leviton encourages investors who have lost money to contact them for assistance in recovering losses [5]. - The firm is recognized as a leading securities class action firm, having recovered billions for defrauded investors through litigation [7].

NEW YORK, Dec. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of CarMax, Inc. (NYSE: KMX). Shareholders who purchased shares of KMX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/carmax-inc-loss-submission-form/?id=179982&from=4 CLASS PERIOD: June 20, 2025 to November 5, ...

Core Viewpoint - A class action lawsuit has been filed against Inspire Medical Systems, Inc. for alleged violations of securities laws, specifically related to misleading statements about the launch of its Inspire V therapy system [1][2]. Group 1: Lawsuit Details - The class period for the lawsuit is from August 6, 2024, to August 4, 2025, with a deadline for lead plaintiff appointments set for January 5, 2026 [2]. - The complaint alleges that Inspire Medical Systems made false and misleading statements, leading investors to believe in strong market demand for the Inspire V therapy system, which ultimately faced weak demand upon launch [2]. Group 2: Investor Participation - Shareholders who purchased shares during the class period are encouraged to contact the law firm for potential lead plaintiff appointments, although such an appointment is not necessary to participate in any recovery [2][3]. Group 3: Law Firm Background - DJS Law Group specializes in securities class actions and corporate governance litigation, focusing on enhancing investor returns through advocacy [4].

NEW YORK, Dec. 8, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Telix Pharmaceuticals Ltd. (NASDAQ: TLX). Shareholders who purchased shares of TLX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/telix-pharmaceuticals-ltd-loss-submission-form/?id=179723&from=4 CLASS PERIOD ...

NEW YORK, Dec. 1, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Skye Bioscience, Inc. (NASDAQ: SKYE). Shareholders who purchased shares of SKYE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/skye-bioscience-inc-loss-submission-form/?id=179139&from=4 Accessibility Stateme ...

Core Viewpoint - A class action lawsuit has been filed against Perrigo Company plc for alleged violations of securities laws, specifically related to misleading statements made after its acquisition of Nestlé's baby formula business [1][2]. Group 1: Lawsuit Details - The class period for the lawsuit is from February 27, 2025, to November 4, 2025, with a deadline for lead plaintiff appointments set for January 16, 2026 [2]. - The complaint alleges that Perrigo made false and misleading statements regarding the condition of the acquired business, which required significant investments for maintenance and repairs [2]. Group 2: Investor Participation - Shareholders who purchased shares during the class period are encouraged to contact the law firm for potential lead plaintiff appointments, although this is not necessary to participate in any recovery [2][3]. - Once registered, shareholders will be enrolled in a portfolio monitoring system to receive updates on the case's progress at no cost [3]. Group 3: Law Firm Background - DJS Law Group specializes in securities class actions and corporate governance litigation, representing large hedge funds and alternative asset managers [4].